Lobbying

Guidewell Mutual Holding's latest lobbying report covers Q2 2026, at $70K. The four quarters Q3 2025–Q2 2026 total $215K. Its first report covers Q4 2022; the issues it reports most are Medicare/Medicaid and Pharmacy.

Guidewell Mutual Holding

Latest quarter
$70K
Q2 2026 · 2 reports
Last 12 months
$215K
Last 4 quarters
vs last quarter
+27.3%
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Guidewell Mutual Holding lobbying by quarter
Guidewell Mutual Holding lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$01
Q3 2023$01
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$10K1
Q3 2024$20K1
Q4 2024$10K1
Q1 2025$30K2
Q2 2025$55K2
Q3 2025$45K2
Q4 2025$45K2
Q1 2026$55K2
Q2 2026$70K2

Policy issues the reports name

  • Medicare and Medicaid15 reports
  • Pharmacy15 reports
  • Health issues6 reports

A report that names several issues counts once for each.

Who was lobbied

  • Health & Human Services, Dept of (HHS)21 reports
  • HOUSE OF REPRESENTATIVES21 reports
  • SENATE21 reports
  • Centers For Medicare and Medicaid Services (CMS)15 reports
  • Executive Office of the President (EOP)15 reports
  • Office of Management & Budget (OMB)15 reports
  • White House Office15 reports
  • Labor, Dept of (DOL)4 reports

Firms it paid

Firm
TSG Advocates DC$260K6 quarters
In-houseGuidewell Mutual Holding$100K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/20for Q2In-house$20K
07/20for Q2TSG Advocates DC$50K
04/20for Q1In-house$10K
04/17for Q1TSG Advocates DC$45K
01/20for Q4 2025In-houseUnder $5,000
01/14for Q4 2025TSG Advocates DC$45K
25/10/20for Q3 2025In-houseUnder $5,000
25/10/14for Q3 2025TSG Advocates DC$45K
25/07/21for Q2 2025In-house$10K
25/07/17for Q2 2025TSG Advocates DC$45K
25/07/17for Q1 2025TSG Advocates DC$30K
25/05/29for Q2 2025TSG Advocates DCUnder $5,000
25/05/12for Q2 2025TSG Advocates DCUnder $5,000
25/04/24for Q1 2025TSG Advocates DCUnder $5,000
25/04/21for Q1 2025In-houseUnder $5,000
25/01/17for Q4 2024In-house$10K
24/10/17for Q3 2024In-house$20K
24/07/19for Q2 2024In-house$10K
24/04/18for Q1 2024In-house$10K
24/01/19for Q4 2023In-house$10K